Bone Loss Rate in Adrenal Incidentalomas: A Longitudinal Study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Although by definition patients with adrenal incidentalomas (AI) do not have evident clinical syndromes, they may frequently suffer from subclinical hypercortisolism (SH). This is of some importance because of evidence that SH may lead to clinical complications, including bone loss. Thus, the understanding of bone involvement due to SH may be extremely important in the management of AI. Unfortunately, the available data on bone mineral density (BMD) in AI patients come from cross-sectional studies, which, to further complicate our understanding, are also conflicting, probably due to a different selection of patients and/or the variability in cortisol secretion (CS) often described in AI. To gain further insight about this topic, we performed a longitudinal study evaluating the rate of spinal and femoral bone loss levels in 24 females with AI. AI subjects were subdivided in two groups on the basis of the median of urinary cortisol secretion (UFC): group I (n = 12; UFC, <140.4 nmol/24 h) and group II (n = 12; UFC, >140.4 nmol/24 h). Spinal BMD was measured by both single energy quantitative computed tomography (L1-L4) and dual energy x-ray absorptiometry (DXA; L2-L4), and femoral BMD was determined by DXA. Bone loss rate was expressed as the change in z-score per yr. The spinal bone loss rate was higher (P < 0.005) in group II than in group I when measured by both quantitative computed tomography (-0.19 +/- 0.14 vs. 0.00 +/- 0.15) and DXA (-0.19 +/- 0.17 vs. 0.00 +/- 0.11). Moreover, CS and spinal bone loss rate were significantly correlated when patients were considered together. In conclusion, our data show that 1) AI patients with higher CS have increased lumbar trabecular bone loss rate than those with lower CS; and 2) the degree of spinal bone loss rate is related to the degree of CS. Thus, lumbar spine (LS) BMD has to be evaluated for well balanced decision-making on the treatment of choice for AI female patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Canalis, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3441 · Cited by 463
Rossi, R. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.4.1440 · Cited by 419
Eisman, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0384 · Cited by 376
Reincke, M. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.826 · Cited by 348
Hormonal Evaluation of the Patient with an Incidentally Discovered Adrenal Mass
Desforges, J. F., Ross, N. S., & Aron, D. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232007 · Cited by 340
Incidentally discovered adrenal masses
Kloos, R. T. (1995) · Endocrine Reviews · doi:10.1210/er.16.4.460 · Cited by 267
Angeli, A., Osella, G., Ali, A., & Terzolo, M. (1997) · Hormone Research · doi:10.1159/000185477 · Cited by 259 · cited 1×
“In fact, the knowledge of reduced bone mass may help in making decisions about the need for surgical excision in AI tumors smaller than 4 cm (4, 7).”
BackgroundNormal Reference Laboratory Values
Kratz, A., & Lewandrowski, K. B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391508 · Cited by 209
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Cited by
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
AME Position Statement on adrenal incidentaloma
Terzolo, M., Stigliano, A., Chiodini, I., Loli, P., Furlani, L., Arnaldi, G., Reimondo, G., Pia, A., Toscano, V, Zini, M., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1147 · Cited by 520
Self-citationSherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347
“However, in patients with ACS, a mixed picture is reported with either decreased, normal, or even increased bone formation reported alongside normal bone resorption (229,242,259-262).”
BackgroundDiagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279
Self-citationElhassan, Y. S., Alahdab, F., Prete, A., Delivanis, D. A., Khanna, A., Prokop, L., Murad, M. H., O'Reilly, M. W., Arlt, W., & Bancos, I. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3630 · Cited by 263
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Subclinical Cushing’s syndrome in adrenal incidentalomas
Terzolo, M., Bovio, S., Reimondo, G., Pia, A., Osella, G., Borretta, G., & Angeli, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.008 · Cited by 179
Management of the Clinically Inapparent Adrenal Mass
Braunstein, G. D., & Panel, F. T. N. I. O. H. S.-O.-T. S. A. I. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00019 · Cited by 172
Chiodini, I., Morelli, V., Masserini, B., Salcuni, A. S., Eller-Vainicher, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Carnevale, V., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0468 · Cited by 168
Self-citationSubclinical hypercortisolism among outpatients referred for osteoporosis.
Chiodini, I., Mascia, M. L., Muscarella, S., Battista, C., Minisola, S., Arosio, M., Santini, S. A., Guglielmi, G., Carnevale, V., & Scillitani, A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00006 · Cited by 162
Self-citationSkeletal involvement in patients with diabetes mellitus
Carnevale, V., Romagnoli, E., & D'Erasmo, E. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.449 · Cited by 161
Self-citationKebebew, E. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2031112 · Cited by 198
Eller-Vainicher, C., Morelli, V., Ulivieri, F. M., Palmieri, S., Zhukouskaya, V. V., Cairoli, E., Pino, R., Naccarato, A., Scillitani, A., Beck-Peccoz, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1648 · Cited by 143
Self-citationMorelli, V., Eller-Vainicher, C., Salcuni, A. S., Coletti, F., Iorio, L., Muscogiuri, G., Della Casa, S., Arosio, M., Ambrosi, B., Beck-Peccoz, P., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.398 · Cited by 135
Self-citationEndogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications.
Tsagarakis, S., Vassiliadi, D., & Thalassinos, N. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344133 · Cited by 113
Masserini, B., Morelli, V., Bergamaschi, S., Ermetici, F., Eller-Vainicher, C., Barbieri, A. M., Maffini, M. A., Scillitani, A., Ambrosi, B., Beck-Peccoz, P., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0485 · Cited by 106
Self-citationChiodini, I., Guglielmi, G., Battista, C., Carnevale, V., Torlontano, M., Cammisa, M., Trischitta, V., & Scillitani, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031413 · Cited by 82
“Our data on BMD are in line with previous results obtained by our and other groups in relatively small samples of AI patients, in which spinal areal (determined by dual energy x-ray absorptiometry) and volumetric (by QCT) bone density were cross-sectionally and longitudinally evaluated (12, 15, 18).”
ResultSelf-citationSubclinical Cushing's syndrome.
Terzolo, M., Reimondo, G., Bovio, S., & Angeli, A. (2004) · Pituitary · doi:10.1007/s11102-005-4024-6 · Cited by 80
Skeletal involvement in adult patients with endogenous hypercortisolism
Chiodini, I., Torlontano, M., Carnevale, V., Trischitta, V., & Scillitani, A. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03345601 · Cited by 78
Self-citationAutonomous cortisol secretion in adrenal incidentalomas
Castro, M. A., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-01888-y · Cited by 85
Eller-Vainicher, C., Morelli, V., Salcuni, A. S., Torlontano, M., Coletti, F., Iorio, L., Cuttitta, A., Ambrosio, A., Vicentini, L., Carnevale, V., et al. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0775 · Cited by 75
Self-citationMechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
Self-citationSystematic review of surgical treatment of subclinical Cushing's syndrome
Iacobone, M., Citton, M., Scarpa, M., Viel, G., Boscaro, M., & Nitti, D. (2015) · British Journal of Surgery · doi:10.1002/bjs.9742 · Cited by 72
Adrenal incidentaloma: evaluation and management
Singh, P. K., & Buch, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044313 · Cited by 79
Chiodini, I., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Ermetici, F., Morelli, V., Salcuni, A., Carnevale, V., Urbano, F., et al. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03310.x · Cited by 72
Self-citationSubclinical Cushing's syndrome
Terzolo, M., Bovio, S., Pia, A., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 69
Chiodini, I., Tauchmanovà, L., Torlontano, M., Battista, C., Guglielmi, G., Cammisa, M., Colao, A., Carnevale, V., Rossi, R., Di Lembo, S., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020399 · Cited by 63
Self-citationSubclinical Cushing’s syndrome
Leo, M. D., Cozzolino, A., Colao, A. A. L., & Pivonello, R. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.02.001 · Cited by 71
Modern management of mild autonomous cortisol secretion
Delivanis, D. A., Athimulam, S., & Bancos, I. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1551 · Cited by 46
The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers
Athimulam, S., Delivanis, D. A., Thomas, M. A., Young, W. F., Khosla, S., Drake, M. T., & Bancos, I. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa120 · Cited by 43
Subclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 35
Moraes, A. B., de Paula, M. P., Paranhos‐Neto, F. D. P., Cavalari, E. M. R., de Morais, F. F. C., Curi, D., Lima, L. F. C., de Mendonça, L. M. C., Farias, M. L. F., Madeira, M., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa263 · Cited by 32
Evaluation of bone health in patients with adrenal tumors
Athimulam, S., & Bancos, I. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000478 · Cited by 34
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 42
Ahn, S. H., Kim, J. H., Cho, Y., Suh, S., Kim, B., Hong, S., Lee, S. H., Koh, J., & Song, K. (2019) · Osteoporosis International · doi:10.1007/s00198-019-04871-5 · Cited by 23
Comorbidities in Mild Autonomous Cortisol Secretion – A Clinical Review of Literature
Czapla-Iskrzycka, A., Świątkowska−Stodulska, R., & Sworczak, K. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1827-4113 · Cited by 23
Pal, R., Banerjee, M., Prasad, T. N., Walia, R., Bhadada, T., Singh, J., & Bhadada, S. K. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae067 · Cited by 25
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.01.002 · Cited by 21
Health-related quality of life and fatigue in patients with adrenal incidentaloma
Kaštelan, D., Džubur, F., Dušek, T., Poljičanin, T., Crnčević-Orlić, Ž., Kraljević, I., Solak, M., Bencevic, T., Aganović, I., Knežević, N., et al. (2011) · Endocrine · doi:10.1007/s12020-011-9456-3 · Cited by 20
Evans, K. D., Douglas, B., BRUCE, N. W., & Drummond, P. D. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00285.x · Cited by 16
Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives
Altieri, B., Muscogiuri, G., Paschou, S. Α., Vryonidou, A., Casa, S. D., Pontecorvi, A., Faßnacht, M., Ronchi, C. L., & Newell-Price, J. D. C. (2018) · Endocrine · doi:10.1007/s12020-018-1696-z · Cited by 17
Corticosteroid-Induced Osteoporosis: An Update for Dermatologists
Clarke, B. L. (2012) · American Journal of Clinical Dermatology · doi:10.2165/11594250-000000000-00000 · Cited by 20
Ren, X., Nan, M., & Zhang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1399311 · Cited by 21
When to Intervene for Subclinical Cushing's Syndrome
Hsieh, L. B., MacKinney, E. C., & Wang, T. S. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.011 · Cited by 17
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis
Felšöci, M., Schroner, Z., Petrovičová, J., & Lazúrová, I. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1497-8 · Cited by 13
Ishida, A., Igarashi, K., Ruike, Y., Ishiwata, K., Naito, K., Kono, S., Deguchi, H., Fujimoto, M., Shiga, A., Suzuki, S., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14385 · Cited by 12
Evaluation of Adrenal Incidentaloma
Hu, J., Kassu, R. A., Titanji, B. N., & Kebebew, E. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.02.012 · Cited by 13
Hypercortisolism as a Potential Concern for Submariners
Reini, S. A. (2010) · Aviation Space and Environmental Medicine · doi:10.3357/asem.2875.2010 · Cited by 13
Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Bednarek-Tupikowska, G. (2013) · PubMed · Cited by 10
Mansour, N., Brüdgam, D., Heinrich, D. A., Dischinger, U., Reisch, N., Völter, F., Stüfchen, I., Nowak, E., Zopp, S., Vasileva, V., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1521680 · Cited by 6
Reyes‐García, R., Gimeno, E. J., Martín, A. G., Muñoz, M. R., Sáez, J. M. G., Fernández, I. L., Varsavsky, M., Iglesias, S. G., Rodríguez, I. C., Ballesteros-Pomar, M. D., et al. (2012) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2012.01.004 · Cited by 7
Turcu, A. F., & Auchus, R. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_10 · Cited by 4
Clinically Inapparent Adrenal Mass (Incidentaloma or Adrenaloma)
Linos, D. A. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_24 · Cited by 3
Management of adrenal incidentaloma
Kaštelan, D. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.75 · Cited by 1
Relevance and perspective concept of investigation of subclinical Cushing syndrome.
Kuznetsov, N. S., Latkina, N. V., & Kaminarskaya, Y. A. (2016) · Endocrine Surgery · doi:10.14341/serg2016113-22 · Cited by 2
Síndrome de Cushing subclínico
Salvador, J., gÓmez, F., & Santos, E. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74618-5 · Cited by 1
Osteoporosi e ipercortisolismo subclinico
Morelli, V., Palmieri, S., & Chiodini, I. (2011) · L Endocrinologo · doi:10.1007/bf03344854
Self-citationLe syndrome de Cushing infraclinique en cardiologie
Amar, J. (2010) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(10)70144-9
Bohdanowicz-Pawlak, A., Szymczak, J., Waszczuk, E., Bolanowski, M., & Therapy, I. (2013)
"Diagnóstico e tratamento das massas adrenais clinicamente silenciosas: revisão de literatura"
Sette, M. J. A. (2005) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2005.tde-21122005-154758 · Cited by 1
Reyes‐García, R., Gimeno, E. J., & Martín, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00023-x
Subclinical Cushing’s syndrome: lots of questions — little answers
Rybakov, S. I. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.6.2021.243216
Linos, D. A. (2009) · Springer eBooks · doi:10.1007/978-1-84628-881-4_31
Adrenal insidentaloma’lı hastalarda klinik, biyokimyasal ve radyolojik retrospektif analiz
Eser, Z. E., Gen, R., Eser, K., Sezer, K., & Akbay, E. (2022) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.1109724 · Cited by 1
Trandafir, A.-I., Stanciu, M., Albu, S. E., Stoian, V. R., CIOFU, I., Persu, C., Nistor, C., & Carşote, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134244 · Cited by 2
Eser, Z. E., Gen, R., Eser, K., Sezer, K., & Akbay, E. (2024) · Proceedings of Anticancer Research · doi:10.26689/par.v8i1.6105
Trandafir, A.-I., Stanciu, M., Valea, A., Sima, O.-C., Nistor, C., Iliescu, M. G., Ciobanu, I., Popa, F. L., & Carşote, M. (2024) · Balneo and PRM Research Journal · doi:10.12680/balneo.2024.692
Metadata
- Authors
- Chiodini, I., Torlontano, M., Carnevale, V., Guglielmi, G., Cammisa, M., Trischitta, V., & Scillitani, A.
- Affiliations
- Casa Sollievo della Sofferenza (IT)
- Corresponding author
- Scillitani, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-11
- Volume
- 86
- Issue
- 11
- Pages
- 5337-5341
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2071760720
- Cited by
- 69
- References
- 31
- Citations by year
- 2024: 6 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 2 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 2 · 2012: 5
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- adrenal incidentaloma, bone loss rate, subclinical hypercortisolism, bone mineral density, urinary free cortisol, lumbar spine, femoral bone density, trabecular bone loss, cortisol secretion, women
- MeSH terms
- Adrenal Gland Neoplasms, Adult, Aged, Female, Femur, Hormones, Humans, Hydrocortisone, Longitudinal Studies, Menopause, Menstrual Cycle, Middle Aged, Spine, Bone Density
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.